Product
Lung Spheroid Stem Cells
Aliases
LSCs
1 clinical trial
1 indication
Indication
Idiopathic Pulmonary FibrosisClinical trial
A Phase I, Randomized Study of the Safety and Efficacy of Intravenous Delivery of Lung Spheroid Stem Cells (LSCs) in Patients With Idiopathic Pulmonary FibrosisStatus: Recruiting, Estimated PCD: 2026-03-01